ASST Grande Ospedale Metropolitano Niguarda — Milan

Public research footprint of ASST Grande Ospedale Metropolitano Niguarda, compiled from the ClinicalTrials.gov public registry.

395

Registered studies

201

Active

112

Recruiting now

139

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Follicular Lymphoma · Untreated, Unresectable, or Metastatic Colorectal Cancer · Carcinoma, Non-Small-Cell Lung

Recently updated registry entries

NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)
NCT01804686 — A Long-term Extension Study of PCI-32765 (Ibrutinib) (Recruiting)
NCT05217446 — A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at ASST Grande Ospedale Metropolitano Niguarda?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.